The number of children in the United States diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD) increased from 6.1 percent to 10.2 percent from 1997 to 2016, according to an analysis from the University of Iowa published in the Journal of the American Medical Association (JAMA) Network Open.

Results published Aug. 28 contain the clinical trial evidence on which the FDA recently approved for clinical use the IDx-DR—the first medical device to use artificial intelligence for the autonomous detection of diabetic retinopathy. UI ophthalmologist Michael Abràmoff, MD, PhD, is the study's principal investigator and president of IDx, the company that brought his idea to reality.

Current graduate student Bertha Martin recently participated in the National Scientific Mentoring and Diversity Program (SMDP) Biotech, a one-year career mentoring program that pairs ethnically diverse students and early career researchers with industry mentors.